Gastroesophageal Reflux Disease (GERD) Market Report

Europe Gastroesophageal Reflux Disease (GERD) Market Size, Status and Forecast 2014-2026

  • POSTDATE：Oct 19, 2019
  • PAGES：168
  • REPORT CODE：GMM331645
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The Gastroesophageal Reflux Disease (GERD) market was valued at XX.0 Million US$ in 2018 and is projected to reach XX.0 Million US$ by 2026, at a CAGR (Compound Annual Growth Rate) of 3.2% during the forecast period. Focusing on the Europe market, this report analyzes the specific consumption structure, such as types and end users. In order to present the status of the circulation of this product in different Europe countries, this report covers top export and import countries to confirm the potential markets. Leading countries such as Germany, UK, France, Italy, Spain, Poland, Russia, Switzerland, Turkey, Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden), Benelux (Belgium, Netherlands, and Luxembourg), Baltic States (Estonia, Latvia, and Lithuania) and other countries, the market status and consumption potential of these countries are covered in the research, providing valuable opinions of strategic adjustments for existing groups and new entrants.

    The Snapshot of Europe Gastroesophageal Reflux Disease (GERD) Market Segmentations:

    By Player:

    • Johnson and Johnson

    • GlaxoSmithKline

    • SFJ Pharmaceuticals Group

    • AstraZeneca

    • CJ Cheil Jedang

    • Daewoong Pharmaceutical

    • Vecta Pharmaceuticals

    • Eisai

    • Zeria Pharmaceuticals

    • Takeda

    By Type:

    • Proton Pumps Inhibitors

    • H2 Receptor Antagonists

    • Antacids

    • Prokinetics

    • Others

    By End-User:

    • Hospital

    • Clinic

    • Retail Pharmacies

    • Online Pharmacies

    By Region:

    • Germany

    • UK

    • France

    • Italy

    • Spain

    • Poland

    • Russia

    • Switzerland

    • Turkey

    • Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden)

      • Denmark

      • Finland

      • Norway

      • Sweden

      • Iceland

    • Benelux (Belgium, Netherlands, and Luxembourg)

      • Belgium

      • Netherlands

      • Luxembourg

    • Baltic States (Estonia, Latvia, and Lithuania)

      • Estonia

      • Latvia

      • Lithuania

  • Table of Contents

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Gastroesophageal Reflux Disease (GERD) Market

    • 1.3 Market Segment by Type

    • 1.3.1 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Proton Pumps Inhibitors from 2014 to 2026

    • 1.3.2 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of H2 Receptor Antagonists from 2014 to 2026

    • 1.3.3 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Antacids from 2014 to 2026

    • 1.3.4 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Prokinetics from 2014 to 2026

    • 1.3.5 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Others from 2014 to 2026

    • 1.4 Market Segment by Application

    • 1.4.1 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Hospital from 2014 to 2026

    • 1.4.2 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Clinic from 2014 to 2026

    • 1.4.3 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • 1.4.4 Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • 1.5 Market Segment by Regions

      • 1.5.1 Germany Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.2 UK Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.3 France Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.4 Italy Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.5 Spain Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.6 Poland Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.7 Russia Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.8 Switzerland Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.9 Turkey Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

      • 1.5.12 Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    3 Segmentation of Gastroesophageal Reflux Disease (GERD) Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Commercial Products Types of Major Venders

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Gastroesophageal Reflux Disease (GERD) by Major Types

      • 3.4.1 Market Size and Growth Rate of Proton Pumps Inhibitors

      • 3.4.2 Market Size and Growth Rate of H2 Receptor Antagonists

      • 3.4.3 Market Size and Growth Rate of Antacids

      • 3.4.4 Market Size and Growth Rate of Prokinetics

      • 3.4.5 Market Size and Growth Rate of Others

    4 Segmentation of Gastroesophageal Reflux Disease (GERD) Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Gastroesophageal Reflux Disease (GERD) by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Gastroesophageal Reflux Disease (GERD) for Hospital

      • 4.4.2 Market Size and Growth Rate of Gastroesophageal Reflux Disease (GERD) for Clinic

      • 4.4.3 Market Size and Growth Rate of Gastroesophageal Reflux Disease (GERD) for Retail Pharmacies

      • 4.4.4 Market Size and Growth Rate of Gastroesophageal Reflux Disease (GERD) for Online Pharmacies

    5 Market Analysis by Major Regions

    • 5.1 Europe Gastroesophageal Reflux Disease (GERD) Production Analysis by Top Regions

    • 5.2 Europe Gastroesophageal Reflux Disease (GERD) Consumption Analysis by Top Regions

    • 5.3 Europe Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis by Regions

      • 5.3.1 Germany Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.2 UK Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.3 France Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.4 Italy Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.5 Spain Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.6 Poland Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.7 Russia Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.8 Switzerland Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.9 Turkey Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.10 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.11 Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

      • 5.3.12 Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    6 Product Circulation of Gastroesophageal Reflux Disease (GERD) Market among Top Countries

    • 6.1 Top 5 Export Countries in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

      • 6.1.1 Top 5 Export Countries’ Export Value Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

      • 6.1.2 Top 5 Export Countries’ Export Volume Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

    • 6.2 Top 5 Import Countries in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

      • 6.2.1 Top 5 Import Countries’ Import Value Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

      • 6.2.2 Top 5 Import Countries’ Import Volume Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

    • 6.3 Emerging Top 3 Export Countries Analysis

    • 6.4 Emerging Top 3 Import Countries Analysis

    7. Germany Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 7.1 Germany Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 7.2 Germany Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    8. UK Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 8.1 UK Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 8.2 UK Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    9. France Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 9.1 France Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 9.2 France Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    10. Italy Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 10.1 Italy Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 10.2 Italy Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    11. Spain Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 11.1 Spain Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 11.2 Spain Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    12. Poland Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 12.1 Poland Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 12.2 Poland Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    13. Russia Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 13.1 Russia Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 13.2 Russia Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    14. Switzerland Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 14.1 Switzerland Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 14.2 Switzerland Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    15. Turkey Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 15.1 Turkey Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 15.2 Turkey Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    16. Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 16.1 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 16.2 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    • 16.3 Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Top Countries

      • 16.3.1 Denmark Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 16.3.2 Finland Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 16.3.3 Norway Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 16.3.4 Sweden Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 16.3.6 Iceland Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

    17 Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 17.1 Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 17.2 Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    • 17.3 Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Top Countries

      • 17.3.1 Belgium Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 17.3.2 Netherlands Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 17.3.3 Luxembourg Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

    18 Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Landscape Analysis

    • 18.1 Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major Types

    • 18.2 Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Major End-Users

    • 18.3 Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Landscape Analysis by Top Countries

      • 18.3.1 Estonia Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 18.3.2 Latvia Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

      • 18.3.3 Lithuania Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate

    19 Major Players Profiles

    • 19.1 Johnson and Johnson

      • 19.1.1 Johnson and Johnson Company Profile and Development Status

      • 19.1.2 Market Performance

      • 19.1.3 Product and Service Introduction

    • 19.2 GlaxoSmithKline

      • 19.2.1 GlaxoSmithKline Company Profile and Development Status

      • 19.2.2 Market Performance

      • 19.2.3 Product and Service Introduction

    • 19.3 SFJ Pharmaceuticals Group

      • 19.3.1 SFJ Pharmaceuticals Group Company Profile and Development Status

      • 19.3.2 Market Performance

      • 19.3.3 Product and Service Introduction

    • 19.4 AstraZeneca

      • 19.4.1 AstraZeneca Company Profile and Development Status

      • 19.4.2 Market Performance

      • 19.4.3 Product and Service Introduction

    • 19.5 CJ Cheil Jedang

      • 19.5.1 CJ Cheil Jedang Company Profile and Development Status

      • 19.5.2 Market Performance

      • 19.5.3 Product and Service Introduction

    • 19.6 Daewoong Pharmaceutical

      • 19.6.1 Daewoong Pharmaceutical Company Profile and Development Status

      • 19.6.2 Market Performance

      • 19.6.3 Product and Service Introduction

    • 19.7 Vecta Pharmaceuticals

      • 19.7.1 Vecta Pharmaceuticals Company Profile and Development Status

      • 19.7.2 Market Performance

      • 19.7.3 Product and Service Introduction

    • 19.8 Eisai

      • 19.8.1 Eisai Company Profile and Development Status

      • 19.8.2 Market Performance

      • 19.8.3 Product and Service Introduction

    • 19.9 Zeria Pharmaceuticals

      • 19.9.1 Zeria Pharmaceuticals Company Profile and Development Status

      • 19.9.2 Market Performance

      • 19.9.3 Product and Service Introduction

    • 19.10 Takeda

      • 19.10.1 Takeda Company Profile and Development Status

      • 19.10.2 Market Performance

      • 19.10.3 Product and Service Introduction

    The List of Tables and Figures (Totals 65 Figures and 160 Tables)

    • Figure Product Picture

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Proton Pumps Inhibitors from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of H2 Receptor Antagonists from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Antacids from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Prokinetics from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Others from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Hospital from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Clinic from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Retail Pharmacies from 2014 to 2026

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate of Online Pharmacies from 2014 to 2026

    • Figure Germany Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure UK Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure France Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Italy Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Spain Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Poland Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Russia Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Switzerland Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Turkey Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Canada Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Mexico Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Denmark Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Finland Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Norway Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Sweden Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Iceland Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Belgium Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Estonia Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Latvia Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Lithuania Gastroesophageal Reflux Disease (GERD) Market Size and Growth Rate from 2014 to 2026

    • Figure Development Trends and Industry Dynamics of Gastroesophageal Reflux Disease (GERD) Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 6 Players from 2014 to 2019

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Table Specifications of Different Types of Gastroesophageal Reflux Disease (GERD)

    • Figure Development Trends of Different Types

    • Table Commercial Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Gastroesophageal Reflux Disease (GERD) by Different Types from 2014 to 2026

    • Table Consumption Share of Gastroesophageal Reflux Disease (GERD) by Different Types from 2014 to 2026

    • Figure Market Size and Growth Rate of Proton Pumps Inhibitors

    • Figure Market Size and Growth Rate of H2 Receptor Antagonists

    • Figure Market Size and Growth Rate of Antacids

    • Figure Market Size and Growth Rate of Prokinetics

    • Figure Market Size and Growth Rate of Others

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Table Consumption of Gastroesophageal Reflux Disease (GERD) by Different End-Users from 2014 to 2026

    • Table Consumption Share of Gastroesophageal Reflux Disease (GERD) by Different End-Users from 2014 to 2026

    • Figure Market Size and Growth Rate of Hospital

    • Figure Market Size and Growth Rate of Clinic

    • Figure Market Size and Growth Rate of Retail Pharmacies

    • Figure Market Size and Growth Rate of Online Pharmacies

    • Table Europe Gastroesophageal Reflux Disease (GERD) Production by Major Regions

    • Table Europe Gastroesophageal Reflux Disease (GERD) Production Share by Major Regions

    • Figure Europe Gastroesophageal Reflux Disease (GERD) Production Share by Major Countries and Regions in 2014

    • Table Europe Gastroesophageal Reflux Disease (GERD) Consumption by Major Regions

    • Table Europe Gastroesophageal Reflux Disease (GERD) Consumption Share by Major Regions

    • Table Germany Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table UK Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table France Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Italy Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Spain Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Poland Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Russia Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Switzerland Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Turkey Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Production, Import, Consumption and Export Analysis

    • Table Top 5 Export Countries' Export Value Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

    • Table Top 5 Export Countries' Export Volume Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Value Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

    • Table Top 5 Import Countries' Import Volume Analysis in Gastroesophageal Reflux Disease (GERD) Market from 2014 to 2019

    • Figure Emerging Top 3 Export Countries Analysis

    • Figure Emerging Top 3 Import Countries Analysis

    • Table Germany Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Germany Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Germany Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Germany Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table UK Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table UK Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table UK Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table UK Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table France Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table France Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table France Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table France Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Italy Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Italy Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Italy Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Italy Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Spain Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Spain Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Spain Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Spain Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Poland Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Poland Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Poland Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Poland Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Russia Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Russia Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Russia Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Russia Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Switzerland Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Switzerland Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Switzerland Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Switzerland Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Turkey Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Turkey Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Turkey Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Turkey Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Consumption by Major Countries from 2014 to 2026

    • Table Nordic Countries (Denmark, Finland, Iceland, Norway and Sweden) Gastroesophageal Reflux Disease (GERD) Consumption Share by Major Countries from 2014 to 2026

    • Figure Denmark Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Finland Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Norway Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Sweden Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Iceland Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Consumption by Major Countries from 2014 to 2026

    • Table Benelux (Belgium, Netherlands, and Luxembourg) Gastroesophageal Reflux Disease (GERD) Consumption Share by Major Countries from 2014 to 2026

    • Figure Belgium Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Netherlands Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Luxembourg Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Consumption by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Consumption Share by Types from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Consumption by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Consumption Share by End-Users from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Consumption by Major Countries from 2014 to 2026

    • Table Baltic States (Estonia, Latvia, and Lithuania) Gastroesophageal Reflux Disease (GERD) Consumption Share by Major Countries from 2014 to 2026

    • Figure Estonia Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Latvia Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Figure Lithuania Countries Gastroesophageal Reflux Disease (GERD) Market Volume and Growth Rate from 2014 to 2026

    • Table Company Profile and Development Status of Johnson and Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson and Johnson

    • Figure Sales and Growth Rate Analysis of Johnson and Johnson

    • Figure Revenue and Market Share Analysis of Johnson and Johnson

    • Table Product and Service Introduction of Johnson and Johnson

    • Table Company Profile and Development Status of GlaxoSmithKline

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of GlaxoSmithKline

    • Figure Sales and Growth Rate Analysis of GlaxoSmithKline

    • Figure Revenue and Market Share Analysis of GlaxoSmithKline

    • Table Product and Service Introduction of GlaxoSmithKline

    • Table Company Profile and Development Status of SFJ Pharmaceuticals Group

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of SFJ Pharmaceuticals Group

    • Figure Sales and Growth Rate Analysis of SFJ Pharmaceuticals Group

    • Figure Revenue and Market Share Analysis of SFJ Pharmaceuticals Group

    • Table Product and Service Introduction of SFJ Pharmaceuticals Group

    • Table Company Profile and Development Status of AstraZeneca

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of AstraZeneca

    • Figure Sales and Growth Rate Analysis of AstraZeneca

    • Figure Revenue and Market Share Analysis of AstraZeneca

    • Table Product and Service Introduction of AstraZeneca

    • Table Company Profile and Development Status of CJ Cheil Jedang

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of CJ Cheil Jedang

    • Figure Sales and Growth Rate Analysis of CJ Cheil Jedang

    • Figure Revenue and Market Share Analysis of CJ Cheil Jedang

    • Table Product and Service Introduction of CJ Cheil Jedang

    • Table Company Profile and Development Status of Daewoong Pharmaceutical

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Daewoong Pharmaceutical

    • Figure Sales and Growth Rate Analysis of Daewoong Pharmaceutical

    • Figure Revenue and Market Share Analysis of Daewoong Pharmaceutical

    • Table Product and Service Introduction of Daewoong Pharmaceutical

    • Table Company Profile and Development Status of Vecta Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Vecta Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Vecta Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Vecta Pharmaceuticals

    • Table Product and Service Introduction of Vecta Pharmaceuticals

    • Table Company Profile and Development Status of Eisai

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Eisai

    • Figure Sales and Growth Rate Analysis of Eisai

    • Figure Revenue and Market Share Analysis of Eisai

    • Table Product and Service Introduction of Eisai

    • Table Company Profile and Development Status of Zeria Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Zeria Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Zeria Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Zeria Pharmaceuticals

    • Table Product and Service Introduction of Zeria Pharmaceuticals

    • Table Company Profile and Development Status of Takeda

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Takeda

    • Figure Sales and Growth Rate Analysis of Takeda

    • Figure Revenue and Market Share Analysis of Takeda

    • Table Product and Service Introduction of Takeda

Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US